Anaplastic large cell lymphoma epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 5: | Line 5: | ||
Anaplastic large cell lymphoma is a common disease that tends to affect children or young adults. Males are more commonly affected with anaplastic large cell lymphoma than females.<small><ref Name= Cancer.ca> Anaplastic large cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/anaplastic-large-cell-lymphoma/?region=on Accessed on October 7, 2015</ref></small> | Anaplastic large cell lymphoma is a common disease that tends to affect children or young adults. Males are more commonly affected with anaplastic large cell lymphoma than females.<small><ref Name= Cancer.ca> Anaplastic large cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/anaplastic-large-cell-lymphoma/?region=on Accessed on October 7, 2015</ref></small> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Age<small><ref Name= Cancer.ca> Anaplastic large cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/anaplastic-large-cell-lymphoma/?region=on Accessed on October 7, 2015</ref></small> | ===Age=== | ||
* Patients of all age groups may develop anapastic large cell lymphoma <small><ref Name= Cancer.ca> Anaplastic large cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/anaplastic-large-cell-lymphoma/?region=on Accessed on October 7, 2015</ref></small> | |||
* Anaplastic large cell lymphoma is a common disease that tends to affect children or young adults | * Anaplastic large cell lymphoma is a common disease that tends to affect children or young adults | ||
* ALK-positive anaplastic large cell lymphoma usually affects younger individuals (between 10 and 29 years)<ref name="pmid11090048">{{cite journal| author=Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K et al.| title=CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. | journal=Blood | year= 2000 | volume= 96 | issue= 12 | pages= 3681-95 | pmid=11090048 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11090048 }} </ref> | * ALK-positive anaplastic large cell lymphoma usually affects younger individuals (between 10 and 29 years)<ref name="pmid11090048">{{cite journal| author=Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K et al.| title=CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. | journal=Blood | year= 2000 | volume= 96 | issue= 12 | pages= 3681-95 | pmid=11090048 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11090048 }} </ref> | ||
* ALK-negative anaplastic large cell lymphoma usually affects older individuals (between 40-60 years) | * ALK-negative anaplastic large cell lymphoma usually affects older individuals (between 40-60 years) | ||
===Gender<small><ref Name= Cancer.ca> Anaplastic large cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/anaplastic-large-cell-lymphoma/?region=on Accessed on October 7, 2015</ref></small> | ===Gender=== | ||
* Males are more commonly affected with anaplastic large cell lymphoma than females<small><ref Name= Cancer.ca> Anaplastic large cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/anaplastic-large-cell-lymphoma/?region=on Accessed on October 7, 2015</ref></small> | |||
==References== | ==References== |
Revision as of 18:16, 23 November 2015
Anaplastic large cell lymphoma Microchapters |
Differentiating Anaplastic large cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Anaplastic large cell lymphoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Anaplastic large cell lymphoma epidemiology and demographics |
FDA on Anaplastic large cell lymphoma epidemiology and demographics |
CDC on Anaplastic large cell lymphoma epidemiology and demographics |
Anaplastic large cell lymphoma epidemiology and demographics in the news |
Blogs on Anaplastic large cell lymphoma epidemiology and demographics |
Directions to Hospitals Treating Anaplastic large cell lymphoma |
Risk calculators and risk factors for Anaplastic large cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Anaplastic large cell lymphoma is a common disease that tends to affect children or young adults. Males are more commonly affected with anaplastic large cell lymphoma than females.[1]
Epidemiology and Demographics
Age
- Patients of all age groups may develop anapastic large cell lymphoma [1]
- Anaplastic large cell lymphoma is a common disease that tends to affect children or young adults
- ALK-positive anaplastic large cell lymphoma usually affects younger individuals (between 10 and 29 years)[2]
- ALK-negative anaplastic large cell lymphoma usually affects older individuals (between 40-60 years)
Gender
- Males are more commonly affected with anaplastic large cell lymphoma than females[1]
References
- ↑ 1.0 1.1 1.2 Anaplastic large cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/anaplastic-large-cell-lymphoma/?region=on Accessed on October 7, 2015
- ↑ Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K; et al. (2000). "CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features". Blood. 96 (12): 3681–95. PMID 11090048.